| Type | Private |
|---|---|
| Industry | Healthcare, Information Services, Technology |
| Founded | 1954 |
| Headquarters | Danbury, Connecticut |
| Key people | Ari Bousbib, CEO |
| Products | Healthcare Measurement, Analytics & Services, Consulting |
| Owner(s) | TPG Capital CPP Investment Board Leonard Green & Partners |
| Employees | 7,600+ |
| Website | www.imshealth.com |
IMS Health is a global company that provides information, services and technology for the healthcare industry. IMS Health was founded in 1954 by Bill Frohlich and David Dubow. In 2010, IMS Health was taken private by TPG Capital, CPP Investment Board and Leonard Green & Partners.[1] Ari Bousbib is IMS Health’s Chairman and Chief Executive Officer. Bousbib, a long-time senior executive at United Technologies Corporation[2], joined IMS in September 2010.[3] IMS Health recently moved its headquarters from Norwalk, CT to Danbury, CT[4].
Contents |
IMS Health provides analytics, on-shore and off-shore commercial services, and business intelligence platforms to its healthcare clients in more than 100 countries.
IMS’s products and services are used by companies to develop commercialization plans[5] and portfolio strategies[6], to select relevant patient and physician populations[7] for specific therapies, and to measure the effectiveness of pharmaceutical marketing and sales resources.
IMS also uses their own data to produce syndicated reports such as market forecasts. These predict how a market in a specific country or specific therapy area will change over time. This works through the production of baseline projections of sales and the application of different future events to this baseline to produce a forecast.
The original name of the company was Intercontinental Marketing Services, hence the IMS moniker. IMS Health's corporate headquarters is located in Danbury, Connecticut. The company's chairman and chief executive officer is Ari Bousbib.
In 2011, IMS ranked fourth on IDC Health Insights’ list of top 5 preferred life science technology vendors for IT services (Perspective: IDC Health Insights' Top 5 Preferred Life Science Technology Vendors for 2011, Eric Newmark, Program Director Business Systems Strategies, Perspective #HI229400 [11])
The ranking is based on the global market intelligence firm’s survey of 135 industry leaders on their planned IT spend:
Table 1: Top 5 Life Science Vendors, 2011
| Hardware | Software | IT Services | ||||
|---|---|---|---|---|---|---|
| Ranking | Vendor | % of Respondents | Vendor | % of Respondents | Vendor | % of Respondents |
| 1 | Dell | 47.8 | Oracle | 29.6 | Accenture | 7.8 |
| 2 | HP | 32.2 | SAP | 15.7 | IBM | 7 |
| 3 | Apple | 27.8 | SAS | 10.4 | HP | 4.3 |
| 4 | IBM | 22.6 | Microsoft | 9.6 | IMS | 2.6 |
| 5 | Cisco | 22.6 | Apple | 9.6 | Cognizant | 1.7 |
| Rank | Company | Sales in 2009 (million USD) |
Growth in % |
|---|---|---|---|
| 1 | Nielsen Company | 5,000.0 | 2.6 |
| 2 | Kantar Group | 2,000 | 2.5 |
| 3 | IMS Health Inc. | 1,958.6 | 8.9 |
| 4 | GfK AG | 1,397.3 | 5.4 |
| 5 | Ipsos | 1,077.0 | 6.5 |
| 6 | Synovate | 739.6 | 9.5 |
| 7 | IRI | 665.0 | 6.6 |
| 8 | Westat | 425.8 | 0.8 |
| 9 | Arbitron | 400.0 | 5.9 |
|
||||||||||||||